Connie Chang
Direttore operativo presso ONL Therapeutics, Inc.
Profilo
Connie Chang is currently the Chief Operating Officer at ONL Therapeutics, Inc. Her former position was Vice President-Corporate Affairs at Millendo Therapeutics, Inc. She received her undergraduate degree from Harvard University and her MBA from Harvard Business School.
Posizioni attive di Connie Chang
| Società | Posizione | Inizio |
|---|---|---|
ONL Therapeutics, Inc.
 ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Direttore operativo | 19/01/2021 |
Precedenti posizioni note di Connie Chang
| Società | Posizione | Fine |
|---|---|---|
| MILLENDO THERAPEUTICS | Corporate Officer/Principal | - |
Formazione di Connie Chang
| Harvard University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- Connie Chang
